-
1
-
-
0031654546
-
Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors
-
Costanzo MR, Naftel DC, Pritzker MR, Heilman JK 3rd, Boehmer JP, Brozena SC, Dec GW, Ventura HO, Kirklin JK, Bourge RC, Miller LW. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors: Cardiac Transplant Research Database. J Heart Lung Transplant. 1998;17:744-753. (Pubitemid 28396983)
-
(1998)
Journal of Heart and Lung Transplantation
, vol.17
, Issue.8
, pp. 744-753
-
-
Costanzo, M.R.1
Naftel, D.C.2
Pritzker, M.R.3
Heilman III, J.K.4
Boehmer, J.P.5
Brozena, S.C.6
Dec, G.W.7
Ventura, H.O.8
Kirklin, J.K.9
Bourge, R.C.10
Miller, L.W.11
-
2
-
-
34547603040
-
Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth Official Adult Heart Transplant Report-2007
-
DOI 10.1016/j.healun.2007.06.004, PII S1053249807005062
-
Taylor DO, Edwards LB, Boucek MM, Trulock EP, Aurora P, Christie J, Dobbels F, Rahmel AO, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant. 2007;26: 769-781. (Pubitemid 47199081)
-
(2007)
Journal of Heart and Lung Transplantation
, vol.26
, Issue.8
, pp. 769-781
-
-
Taylor, D.O.1
Edwards, L.B.2
Boucek, M.M.3
Trulock, E.P.4
Aurora, P.5
Christie, J.6
Dobbels, F.7
Rahmel, A.O.8
Keck, B.M.9
Hertz, M.I.10
-
3
-
-
0027634313
-
24th Bethesda Conference: Cardiac transplantation. Task Force 5: Complications
-
Miller LW, Schlant RC, Kobashigawa J, Kubo S, Renlund DG. 24th Bethesda Conference: cardiac transplantation. Task Force 5: Complications. J Am Coll Cardiol. 1993;22:41-54.
-
(1993)
J Am Coll Cardiol
, vol.22
, pp. 41-54
-
-
Miller, L.W.1
Schlant, R.C.2
Kobashigawa, J.3
Kubo, S.4
Renlund, D.G.5
-
5
-
-
37349072494
-
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation
-
DOI 10.1161/CIRCULATIONAHA.107.692996
-
Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Rihal C, Lerman A, Kushwaha SS. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation. 2007; 116:2726-2733. (Pubitemid 350291245)
-
(2007)
Circulation
, vol.116
, Issue.23
, pp. 2726-2733
-
-
Raichlin, E.1
Bae, J.-H.2
Khalpey, Z.3
Edwards, B.S.4
Kremers, W.K.5
Clavell, A.L.6
Rodeheffer, R.J.7
Frantz, R.P.8
Rihal, C.9
Lerman, A.10
Kushwaha, S.S.11
-
6
-
-
0029119711
-
Effect of pravastatin on outcomes after cardiac transplantation
-
Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA, Kevin T, Hamilton MA, Moriguchi JD, Kawata N, Hage A, Drinkwater DC, Stevenson LW. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621-627.
-
(1995)
N Engl J Med
, vol.333
, pp. 621-627
-
-
Kobashigawa, J.A.1
Katznelson, S.2
Laks, H.3
Johnson, J.A.4
Yeatman, L.5
Wang, X.M.6
Chia, D.7
Terasaki, P.I.8
Sabad, A.9
Cogert, G.A.10
Kevin, T.11
Hamilton, M.A.12
Moriguchi, J.D.13
Kawata, N.14
Hage, A.15
Drinkwater, D.C.16
Stevenson, L.W.17
-
7
-
-
0345161813
-
Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine
-
DOI 10.1097/00007890-199904150-00017
-
Groth CG, Backman L, Morales JM, Calne R, Kreis H, Lang P, Touraine JL, Claesson K, Campistol JM, Durand D, Wramner L, Brattstrom C, Charpentier B. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine: Sirolimus European Renal Transplant Study Group. Transplantation. 1999;67:1036-1042. (Pubitemid 29200856)
-
(1999)
Transplantation
, vol.67
, Issue.7
, pp. 1036-1042
-
-
Groth, C.G.1
Backman, L.2
Morales, J.-M.3
Calne, R.4
Kreis, H.5
Lang, P.6
Touraine, J.-L.7
Claesson, K.8
Campistol, J.M.9
Durand, D.10
Wramner, L.11
Brattstrom, C.12
Charpentier, B.13
-
8
-
-
0028069744
-
Rapamycin: A novel immunosuppressive macrolide
-
Sehgal SN, Molnar-Kimber K, Ocain TD, Weichman BM. Rapamycin: a novel immunosuppressive macrolide. Med Res Rev. 1994;14: 1-22. (Pubitemid 24035973)
-
(1994)
Medicinal Research Reviews
, vol.14
, Issue.1
, pp. 1-22
-
-
Sehgal, S.N.1
Molnar-Kimber, K.2
Ocain, T.D.3
Weichman, B.M.4
-
9
-
-
20844461132
-
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial
-
DOI 10.1161/01.CIR.0000136812.90177.94
-
Keogh A, Richardson M, Ruygrok P, Spratt P, Galbraith A, O'Driscoll G, Macdonald P, Esmore D, Muller D, Faddy S. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation. 2004;110: 2694-2700. (Pubitemid 39453021)
-
(2004)
Circulation
, vol.110
, Issue.17
, pp. 2694-2700
-
-
Keogh, A.1
Richardson, M.2
Ruygrok, P.3
Spratt, P.4
Galbraith, A.5
O'Driscoll, G.6
Macdonald, P.7
Esmore, D.8
Muller, D.9
Faddy, S.10
-
10
-
-
19244366021
-
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
-
DOI 10.1056/NEJMoa022171
-
Eisen HJ, Tuzcu EM, Dorent R, Kobashigawa J, Mancini D, Valantine-von Kaeppler HA, Starling RC, Sorensen K, Hummel M, Lind JM, Abeywickrama KH, Bernhardt P. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med. 2003;349:847-858. (Pubitemid 37025404)
-
(2003)
New England Journal of Medicine
, vol.349
, Issue.9
, pp. 847-858
-
-
Eisen, H.J.1
Tuzcu, E.M.2
Dorent, R.3
Kobashigawa, J.4
Mancini, D.5
Valantine-Von Kaeppler, H.A.6
Starling, R.C.7
Sorensen, K.8
Hummel, M.9
Lind, J.M.10
Abeywickrama, K.H.11
Bernhardt, P.12
-
11
-
-
0038300674
-
Use of rapamycin slows progression of cardiac transplantation vasculopathy
-
DOI 10.1161/01.CIR.0000070421.38604.2B
-
Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation. 2003;108: 48-53. (Pubitemid 36859019)
-
(2003)
Circulation
, vol.108
, Issue.1
, pp. 48-53
-
-
Mancini, D.1
Pinney, S.2
Burkhoff, D.3
LaManca, J.4
Itescu, S.5
Burke, E.6
Edwards, N.7
Oz, M.8
Marks, A.R.9
-
12
-
-
29144480970
-
Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity
-
DOI 10.1016/j.healun.2005.08.015, PII S1053249805005607
-
Kushwaha SS, Khalpey Z, Frantz RP, Rodeheffer RJ, Clavell AL, Daly RC, McGregor CG, Edwards BS. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant. 2005;24:2129-2136. (Pubitemid 41814736)
-
(2005)
Journal of Heart and Lung Transplantation
, vol.24
, Issue.12
, pp. 2129-2136
-
-
Kushwaha, S.S.1
Khalpey, Z.2
Frantz, R.P.3
Rodeheffer, R.J.4
Clavell, A.L.5
Daly, R.C.6
McGregor, C.G.7
Edwards, B.S.8
-
13
-
-
77953726543
-
International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy 2010
-
Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy 2010. J Heart Lung Transplant. 2010;29:717-727.
-
(2010)
J Heart Lung Transplant
, vol.29
, pp. 717-727
-
-
Mehra, M.R.1
Crespo-Leiro, M.G.2
Dipchand, A.3
Ensminger, S.M.4
Hiemann, N.E.5
Kobashigawa, J.A.6
Madsen, J.7
Parameshwar, J.8
Starling, R.C.9
Uber, P.A.10
-
14
-
-
33750294462
-
Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy
-
DOI 10.1097/01.tp.0000230378.61437.a5, PII 0000789020061027000017
-
Bae JH, Rihal CS, Edwards BS, Kushwaha SS, Mathew V, Prasad A, Holmes DR Jr, Lerman A. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation. 2006;82:1108-1111. (Pubitemid 44632129)
-
(2006)
Transplantation
, vol.82
, Issue.8
, pp. 1108-1111
-
-
Bae, J.-H.1
Rihal, C.S.2
Edwards, B.S.3
Kushwaha, S.S.4
Mathew, V.5
Prasad, A.6
Holmes Jr., D.R.7
Lerman, A.8
-
15
-
-
0033165781
-
Volumetric remodeling of the proximal left coronary artery: Early versus late after heart transplantation
-
Pethig K, Heublein B, Meliss RR, Haverich A. Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation. J Am Coll Cardiol. 1999;34:197-203.
-
(1999)
J Am Coll Cardiol
, vol.34
, pp. 197-203
-
-
Pethig, K.1
Heublein, B.2
Meliss, R.R.3
Haverich, A.4
-
16
-
-
0035822684
-
Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: Results from a 5-year serial intravascular ultrasound study
-
Tsutsui H, Ziada KM, Schoenhagen P, Iyisoy A, Magyar WA, Crowe TD, Klingensmith JD, Vince DG, Rincon G, Hobbs RE, Yamagishi M, Nissen SE, Tuzcu EM. Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5-year serial intravascular ultrasound study. Circulation. 2001;104:653-657. (Pubitemid 32738518)
-
(2001)
Circulation
, vol.104
, Issue.6
, pp. 653-657
-
-
Tsutsui, H.1
Ziada, K.M.2
Schoenhagen, P.3
Iyisoy, A.4
Magyar, W.A.5
Crowe, T.D.6
Klingensmith, J.D.7
Vince, D.G.8
Rincon, G.9
Hobbs, R.E.10
Yamagishi, M.11
Nissen, S.E.12
Tuzcu, E.M.13
-
17
-
-
0023276691
-
Compensatory enlargement of human atherosclerotic coronary arteries
-
Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375. (Pubitemid 17079680)
-
(1987)
New England Journal of Medicine
, vol.316
, Issue.22
, pp. 1371-1375
-
-
Glagov, S.1
Weisenberg, E.2
Zarins, C.K.3
-
18
-
-
0344706857
-
Role of compensatory enlargement and shrinkage in transplant coronary artery disease: Serial intravascular ultrasound study
-
Lim TT, Liang DH, Botas J, Schroeder JS, Oesterle SN, Yeung AC. Role of compensatory enlargement and shrinkage in transplant coronary artery disease: serial intravascular ultrasound study. Circulation. 1997;95: 855-859. (Pubitemid 27091525)
-
(1997)
Circulation
, vol.95
, Issue.4
, pp. 855-859
-
-
Lim, T.T.1
Liang, D.H.2
Botas, J.3
Schroeder, J.S.4
Oesterle, S.N.5
Yeung, A.C.6
-
19
-
-
0028876806
-
Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells
-
Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res. 1995;76:412-417.
-
(1995)
Circ Res
, vol.76
, pp. 412-417
-
-
Marx, S.O.1
Jayaraman, T.2
Go, L.O.3
Marks, A.R.4
-
20
-
-
0029845013
-
Rapamycin inhibits vascular smooth muscle cell migration
-
Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest. 1996;98:2277-2283. (Pubitemid 26394201)
-
(1996)
Journal of Clinical Investigation
, vol.98
, Issue.10
, pp. 2277-2283
-
-
Poon, M.1
Marx, S.O.2
Gallo, R.3
Badimon, J.J.4
Taubman, M.B.5
Marks, A.R.6
-
21
-
-
0033206704
-
Novel therapeutic strategies in scleroderma
-
Denton CP, Black CM. Novel therapeutic strategies in scleroderma. Curr Rheumatol Rep. 1999;1:22-27.
-
(1999)
Curr Rheumatol Rep
, vol.1
, pp. 22-27
-
-
Denton, C.P.1
Black, C.M.2
-
22
-
-
0030635702
-
Impact of plaque burden on compensatory enlargement of coronary arteries in cardiac allograft vasculopathy
-
PII S0002914996006868
-
Pethig K, Heublein B, Wahlers T. Impact of plaque burden on compensatory enlargement of coronary arteries in cardiac allograft vasculopathy: Working Group on Cardiac Allograft Vasculopathy. Am J Cardiol. 1997; 79:89-92. (Pubitemid 127673685)
-
(1997)
American Journal of Cardiology
, vol.79
, Issue.1
, pp. 89-92
-
-
Pethig, K.1
Heublein, B.2
Wahlers, T.3
-
23
-
-
63549125193
-
Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression
-
Raichlin E, Bae JH, Kushwaha SS, Lennon RJ, Prasad A, Rihal CS, Lerman A. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol. 2009;53:1279-1286.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 1279-1286
-
-
Raichlin, E.1
Bae, J.H.2
Kushwaha, S.S.3
Lennon, R.J.4
Prasad, A.5
Rihal, C.S.6
Lerman, A.7
-
24
-
-
62949130657
-
Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation
-
Raichlin E, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Pereira NL, Daly RC, McGregor CG, Lerman A, Kushwaha SS. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant. 2009;28:320-327.
-
(2009)
J Heart Lung Transplant
, vol.28
, pp. 320-327
-
-
Raichlin, E.1
Edwards, B.S.2
Kremers, W.K.3
Clavell, A.L.4
Rodeheffer, R.J.5
Frantz, R.P.6
Pereira, N.L.7
Daly, R.C.8
McGregor, C.G.9
Lerman, A.10
Kushwaha, S.S.11
-
25
-
-
0037771087
-
Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis
-
DOI 10.1161/01.CIR.0000081703.34526.5D
-
Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R, Kushwaha SS, Caplice NM. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation. 2003;108:143-149. (Pubitemid 36871294)
-
(2003)
Circulation
, vol.108
, Issue.2
, pp. 143-149
-
-
Simper, D.1
Wang, S.2
Deb, A.3
Holmes, D.4
McGregor, C.5
Frantz, R.6
Kushwaha, S.S.7
Caplice, N.M.8
-
26
-
-
78649934530
-
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy
-
Osto E, Castellani C, Fadini GP, Baesso I, Gambino A, Agostini C, Avogaro A, Gerosa G, Thiene G, Iliceto S, Angelini A, Tona F. Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. J Heart Lung Transplant. 2011;30:70-76.
-
(2011)
J Heart Lung Transplant
, vol.30
, pp. 70-76
-
-
Osto, E.1
Castellani, C.2
Fadini, G.P.3
Baesso, I.4
Gambino, A.5
Agostini, C.6
Avogaro, A.7
Gerosa, G.8
Thiene, G.9
Iliceto, S.10
Angelini, A.11
Tona, F.12
-
27
-
-
77951963246
-
Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients
-
Sathya CJ, Sheshgiri R, Prodger J, Tumiati L, Delgado D, Ross HJ, Rao V. Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients. Transpl Int. 2010;23: 641-648.
-
(2010)
Transpl Int
, vol.23
, pp. 641-648
-
-
Sathya, C.J.1
Sheshgiri, R.2
Prodger, J.3
Tumiati, L.4
Delgado, D.5
Ross, H.J.6
Rao, V.7
-
28
-
-
34247387873
-
+ T cells
-
DOI 10.1038/sj.bmt.1705628, PII 1705628
-
Coenen JJ, Koenen HJ, van Rijssen E, Kasran A, Boon L, Hilbrands LB, Joosten I. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+CD25+Foxp3+T cells. Bone Marrow Transplant. 2007;39:537-545. (Pubitemid 46629589)
-
(2007)
Bone Marrow Transplantation
, vol.39
, Issue.9
, pp. 537-545
-
-
Coenen, J.J.A.1
Koenen, H.J.P.M.2
Van Rijssen, E.3
Kasran, A.4
Boon, L.5
Hilbrands, L.B.6
Joosten, I.7
-
29
-
-
38049177784
-
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+regulatory T cells compared with conventional CD4+T cells
-
Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ, Negrin RS. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+regulatory T cells compared with conventional CD4+T cells. Blood. 2008;111:453-462.
-
(2008)
Blood
, vol.111
, pp. 453-462
-
-
Zeiser, R.1
Leveson-Gower, D.B.2
Zambricki, E.A.3
Kambham, N.4
Beilhack, A.5
Loh, J.6
Hou, J.Z.7
Negrin, R.S.8
-
30
-
-
0034609582
-
Arterial remodeling: Mechanisms and clinical implications
-
Ward MR, Pasterkamp G, Yeung AC, Borst C. Arterial remodeling: mechanisms and clinical implications. Circulation. 2000;102:1186-1191.
-
(2000)
Circulation
, vol.102
, pp. 1186-1191
-
-
Ward, M.R.1
Pasterkamp, G.2
Yeung, A.C.3
Borst, C.4
-
31
-
-
0035081185
-
Cardiac allograft vasculopathy: Adventitial immunoreactivity for PDGF-B and PDGFr-β in extra- versus intramural coronary arteries
-
DOI 10.1016/S0041-1345(00)02600-2, PII S0041134500026002
-
Meliss RR, Pethig K, Schmidt A, Heublein B, Harringer W, Karck M, Choritz H, Haverich A. Cardiac allograft vasculopathy: adventitial immunoreactivity for PDGF-B and PDGFR-beta in extra-versus intramural coronary arteries. Transplant Proc. 2001;33:1579-1580. (Pubitemid 32237980)
-
(2001)
Transplantation Proceedings
, vol.33
, Issue.1-2
, pp. 1579-1580
-
-
Meliss, R.R.1
Pethig, K.2
Schmidt, A.3
Heublein, B.4
Harringer, W.5
Karck, M.6
Choritz, H.7
Haverich, A.8
-
32
-
-
10644288652
-
Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling
-
DOI 10.1016/j.vph.2004.10.002, PII S1537189104001089
-
Hafizi S, Mordi VN, Andersson KM, Chester AH, Yacoub MH. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling. Vasc Pharmacol. 2004;41:167-176. (Pubitemid 39646491)
-
(2004)
Vascular Pharmacology
, vol.41
, Issue.4-5
, pp. 167-176
-
-
Hafizi, S.1
Mordi, V.N.2
Andersson, K.M.3
Chester, A.H.4
Yacoub, M.H.5
-
33
-
-
27844511977
-
Sirolimus inhibits platelet-derived growth factor-induced collagen synthesis in rat vascular smooth muscle cells
-
DOI 10.1016/j.transproceed.2005.09.066, PII S0041134505009917
-
Park J, Ha H, Ahn HJ, Kang SW, Kim YS, Seo JY, Kim MS. Sirolimus inhibits platelet-derived growth factor-induced collagen synthesis in rat vascular smooth muscle cells. Transplant Proc. 2005;37: 3459-3462. (Pubitemid 41659921)
-
(2005)
Transplantation Proceedings
, vol.37
, Issue.8
, pp. 3459-3462
-
-
Park, J.1
Ha, H.2
Ahn, H.J.3
Kang, S.-W.4
Kim, Y.S.5
Seo, J.Y.6
Kim, M.S.7
-
34
-
-
33845938244
-
Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin: A direct role as an antifibrotic agent?
-
DOI 10.1074/jbc.M606366200
-
Poulalhon N, Farge D, Roos N, Tacheau C, Neuzillet C, Michel L, Mauviel A, Verrecchia F. Modulation of collagen and MMP-1 gene expression in fibroblasts by the immunosuppressive drug rapamycin: a direct role as an antifibrotic agent? J Biol Chem. 2006;281:33045-33052. (Pubitemid 46036687)
-
(2006)
Journal of Biological Chemistry
, vol.281
, Issue.44
, pp. 33045-33052
-
-
Poulalhon, N.1
Farge, D.2
Roos, N.3
Tacheau, C.4
Neuzillet, C.5
Michel, L.6
Mauviel, A.7
Verrecchia, F.8
-
35
-
-
33745288559
-
Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients
-
DOI 10.1111/j.1600-6143.2006.01282.x
-
Kuppahally S, Al-Khaldi A, Weisshaar D, Valantine HA, Oyer P, Robbins RC, Hunt SA. Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant. 2006;6:986-992. (Pubitemid 44356648)
-
(2006)
American Journal of Transplantation
, vol.6
, Issue.I5
, pp. 986-992
-
-
Kuppahally, S.1
Al-Khaldi, A.2
Weisshaar, D.3
Valantine, H.A.4
Oyer, P.5
Robbins, R.C.6
Hunt, S.A.7
-
36
-
-
16244393063
-
First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation
-
DOI 10.1111/j.1600-6143.2005.00757.x
-
Meiser B, Reichart B, Adamidis I, Uberfuhr P, Kaczmarek I. First experience with de novo calcineurin-inhibitor-free immunosuppression following cardiac transplantation. Am J Transplant. 2005;5: 827-831. (Pubitemid 40461294)
-
(2005)
American Journal of Transplantation
, vol.5
, Issue.I4
, pp. 827-831
-
-
Meiser, B.1
Reichert, B.2
Adamidis, I.3
Uberfuhr, P.4
Kaczmarek, I.5
-
37
-
-
77952545939
-
Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation
-
Gude E, Gullestad L, Arora S, Simonsen S, Hoel I, Hartmann A, Holdaas H, Fiane AE, Geiran OR, Andreassen AK. Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation. J Heart Lung Transplant. 2010;29:641-647.
-
(2010)
J Heart Lung Transplant
, vol.29
, pp. 641-647
-
-
Gude, E.1
Gullestad, L.2
Arora, S.3
Simonsen, S.4
Hoel, I.5
Hartmann, A.6
Holdaas, H.7
Fiane, A.E.8
Geiran, O.R.9
Andreassen, A.K.10
|